4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001209191-18-021398
Director bought 12,600 shares at an average $7.76 ($97,830)
From the SEC's structured data for this filing
Trades in this filing
Nussbaum Ran · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-03-21 | Purchase : show line 1 in the form | +1,585 | $7.55 | $11,967 | 383,103 | I |
| 2018-03-21 | Purchase : show line 2 in the form | +3,255 | $7.55 | $24,575 | 786,919 | I |
| 2018-03-21 | Purchase : show line 3 in the form | +1,760 | $7.55 | $13,288 | 425,463 | I |
| 2018-03-22 | Purchase : show line 4 in the form | +1,441 | $8.00 | $11,528 | 384,544 | I |
| 2018-03-22 | Purchase : show line 5 in the form | +2,959 | $8.00 | $23,672 | 789,878 | I |
| 2018-03-22 | Purchase : show line 6 in the form | +1,600 | $8.00 | $12,800 | 427,063 | I |
| Open-market purchases · 12,600 sh · avg $7.76 · $97,830 | ||||||
Loading xslF345X03/doc4.xml…